Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 2Diabetes Mellitus, Type 2 2Pulmonary Disease, Chronic Obstructive 1Lung Neoplasms 1Disease 1

Interventions

Surveys and Questionnaires 3Interviews as Topic 3Blood Specimen Collection 3Surgical Procedures, Operative 2Observation 2Magnetic Resonance Imaging 2Liquid Biopsy 2Immunohistochemistry 2Diagnostic Tests, Routine 2Biopsy, Fine-Needle 2Biopsy 2phosphoribosylformylglycinamidine synthetase 1glycidol 1Videotape Recording 1Urination 1Tomography, Optical Coherence 1Th1-Th2 Balance 1Sulfonylurea Compounds 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Serologic Tests 1Sequence Analysis, RNA 1Referral and Consultation 1RNA, Long Noncoding 1Nephroureterectomy 1Mammography 1Laryngoscopy 1In Situ Hybridization 1Histological Techniques 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Disease × Sulfonylurea Compounds × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡